BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23985918)

  • 41. Evaluation of four different diagnostic tests to detect Clostridium difficile in piglets.
    Keessen EC; Hopman NE; van Leengoed LA; van Asten AJ; Hermanus C; Kuijper EJ; Lipman LJ
    J Clin Microbiol; 2011 May; 49(5):1816-21. PubMed ID: 21411571
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical and laboratory characteristics of Clostridium difficile infection in patients with discordant diagnostic test results.
    Kaltsas A; Simon M; Unruh LH; Son C; Wroblewski D; Musser KA; Sepkowitz K; Babady NE; Kamboj M
    J Clin Microbiol; 2012 Apr; 50(4):1303-7. PubMed ID: 22238444
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Screening of
    Baron SW; Ostrowsky BE; Nori P; Drory DY; Levi MH; Szymczak WA; Rinke ML; Southern WN
    Infect Control Hosp Epidemiol; 2020 Feb; 41(2):149-153. PubMed ID: 31822302
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quantification of Clostridium difficile in antibiotic-associated-diarrhea patients.
    Naaber P; Stsepetova J; Smidt I; Rätsep M; Kõljalg S; Lõivukene K; Jaanimäe L; Löhr IH; Natås OB; Truusalu K; Sepp E
    J Clin Microbiol; 2011 Oct; 49(10):3656-8. PubMed ID: 21865427
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effective utilization of C. difficile PCR and identification of clinicopathologic factors associated with conversion to a positive result in symptomatic patients.
    Mostafa ME; Flynn T; Hartley CP; Ledeboer NA; Buchan BW
    Diagn Microbiol Infect Dis; 2018 Apr; 90(4):307-310. PubMed ID: 29290473
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Changing Clostridium difficile infection testing and treatment trends at a large tertiary care teaching hospital.
    Salazar M; Garey KW; Jiang ZD; Dao-Tran T; DuPont H
    Pharm World Sci; 2009 Oct; 31(5):565. PubMed ID: 19657721
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correlation between Clostridium difficile bacterial load, commercial real-time PCR cycle thresholds, and results of diagnostic tests based on enzyme immunoassay and cell culture cytotoxicity assay.
    Dionne LL; Raymond F; Corbeil J; Longtin J; Gervais P; Longtin Y
    J Clin Microbiol; 2013 Nov; 51(11):3624-30. PubMed ID: 23966497
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence of Clostridioides difficile associated diarrhea in hospitalized patients in five Brazilian centers: A multicenter, prospective study.
    Girão ES; de Melo Tavares B; Alves Dos Santos S; Gamarra GL; Rizek C; Martins RC; Perdigão Neto LV; Diogo C; Annibale Orsi T; Sanchez Espinoza EP; Paz Morales HM; da Silva Nogueira K; Maestri AC; Boszczowski I; Piastrelli F; Costa CL; Costa DV; Maciel G; Romão J; Guimarães T; Anne de Castro Brito G; Costa SF
    Anaerobe; 2020 Dec; 66():102267. PubMed ID: 33080372
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The impact of an electronic medical record nudge on reducing testing for hospital-onset
    Howard-Anderson JR; Sexton ME; Robichaux C; Wiley Z; Varkey JB; Suchindran S; Albrecht B; Ashley Jones K; Fridkin SK; Jacob JT
    Infect Control Hosp Epidemiol; 2020 Apr; 41(4):411-417. PubMed ID: 32036798
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An Observational Cohort Study of
    Rao K; Higgins PDR; Young VB
    mSphere; 2018; 3(3):. PubMed ID: 29794054
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Variability in testing policies and impact on reported Clostridium difficile infection rates: results from the pilot Longitudinal European Clostridium difficile Infection Diagnosis surveillance study (LuCID).
    Davies K; Davis G; Barbut F; Eckert C; Petrosillo N; Wilcox MH
    Eur J Clin Microbiol Infect Dis; 2016 Dec; 35(12):1949-1956. PubMed ID: 27590621
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clostridium difficile prevalence rates in a large healthcare system stratified according to patient population, age, gender, and specimen consistency.
    Boone JH; Goodykoontz M; Rhodes SJ; Price K; Smith J; Gearhart KN; Carman RJ; Kerkering TM; Wilkins TD; Lyerly DM
    Eur J Clin Microbiol Infect Dis; 2012 Jul; 31(7):1551-9. PubMed ID: 22167256
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modifications of commercial toxigenic Clostridium difficile PCR resulting in improved economy and workflow efficiency.
    Munson E; Bilbo D; Paul M; Napierala M; Hryciuk JE
    J Clin Microbiol; 2011 Jun; 49(6):2279-82. PubMed ID: 21450967
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical Impact of Clostridium difficile PCR Cycle Threshold-Predicted Toxin Reporting in Pediatric Patients.
    Schwenk HT; Bio LL; Kruger JF; Banaei N
    J Pediatric Infect Dis Soc; 2020 Feb; 9(1):44-50. PubMed ID: 30476169
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reductions in Clostridium difficile Infection (CDI) Rates Using Real-Time Automated Clinical Criteria Verification to Enforce Appropriate Testing.
    Quan KA; Yim J; Merrill D; Khusbu U; Madey K; Dickey L; Dangodara AA; Rudkin SE; O'Brien M; Thompson D; Parekh N; Albers CG; Wilson WC; Thrupp L; Bittencourt CE; Huang SS; Gohil SK
    Infect Control Hosp Epidemiol; 2018 May; 39(5):625-627. PubMed ID: 29552992
    [No Abstract]   [Full Text] [Related]  

  • 56. Three different patterns of positive Clostridium difficile laboratory tests. A comparison of clinical behavior.
    Olmedo M; Alcalá L; Valerio M; Marín M; Onori R; Reigadas E; Muñoz P; Bouza E
    Diagn Microbiol Infect Dis; 2020 Jul; 97(3):115050. PubMed ID: 32482380
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Trends in Clostridioides difficile diagnosis before and after a change in testing algorithm.
    Turner DP; Thorburn SJ; Crowe A; Jardine D; Timmins C
    J Microbiol Methods; 2021 May; 184():106189. PubMed ID: 33689797
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Need for clinicopathologic correlation of Clostridium difficile colitis in view of molecular diagnosis.
    Guarner J; Kraft CS
    Clin Infect Dis; 2012 Jan; 54(1):156. PubMed ID: 22187416
    [No Abstract]   [Full Text] [Related]  

  • 59. Emergence of a highly resistant Clostridium difficile strain (NAP/BI/027) in a tertiary care center in Saudi Arabia.
    Alzahrani N; Johani SA
    Ann Saudi Med; 2013; 33(2):198-9. PubMed ID: 23563012
    [No Abstract]   [Full Text] [Related]  

  • 60. Detection of toxigenic Clostridium difficile in paediatric patients.
    Falces-Romero I; Troyano-Hernáez P; García-Bujalance S; Baquero-Artigao F; Mellado-Peña MJ; García-Rodríguez J
    Enferm Infecc Microbiol Clin (Engl Ed); 2018; 36(6):357-361. PubMed ID: 28689671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.